Estrogen and nitric oxide in vasculature

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue 3, 1999, Pages 230-237

  Kauser, Katalin ^a   Rubanyi, Gabor M ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIUM DERIVED RELAXING FACTOR; ESTRADIOL; ESTROGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME REGULATION; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; INFLAMMATION; MALE; NONHUMAN; POSTMENOPAUSE; RAT; VASODILATATION;

EID: 0033059932     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199906000-00011     Document Type: Article

References (90)

1. Sessa WC: The nitric oxide synthase family of proteins. J Vasc Res 1994, 31:131-143.
2. Rubanyi GM, Kauffman R, eds: Estrogen and the Vessel Wall. London: Harwood Academic Publisher; 1998. This book discusses the potential vasculoprotective effects of estrogen, including regulation of NOSs.
3. Kauser K, Rubanyi GM: Vasculoprotection by estrogen contributes to gender difference in cardiovascular diseases: Potential mechanism and role of endothelium. In The Endothelium in Clinical Practice. Edited by Rubanyi GM, Dzau VJ, New York: Marcel Dekker; 1997;439-467. This is a review of the mechanisms that may contribute to the vasculoprotective effect of estrogen.
4. Kauser K, Rubanyi GM: Potential cellular signaling mechanisms mediating upregulation of endothelial nitric oxide production by estrogen. J Vasc Res 1997, 34:229-236. This review summarizes the possible mechanisms of NOS-3 regulation by estrogen.
5. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G: Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis. Proc Natl Acad Sci U S A 1992, 89:11259-11263.
6. Kauser K, Rubanyi GM: Gender difference in bioassayable endothelium-derived nitric oxide release from isolated rat aortae. Am J Physiol 1994, 267:H2311-H2317.
7. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci U S A 1994, 91:5212-5216.
8. Kauser K, Sonnenberg D, Tse J, Rubanyi GM: 17β-estradiol attenuates endotoxin-induced excessive nitric oxide production in ovariectomized rats in vivo. Am J Physiol 1997, 273:H506-H509. This study demonstrates the inhibitory effect of 17β-estradiol inhibits NOS-2-produced excessive NO production in vivo.
9. Kauser K, Sonnenberg D, Diel P, Rubanyi GM: 1β-estradiol inhibits cytokine-induced nitric oxide production in isolated rat aorta. Br J Pharmacol 1998, 123:1089-1096. This study is the first demonstration of NOS-2 inhibition by 17β-estradiol. It shows decreased expression of NOS-2 protein and mRNA after 17β-estradiol incubation of the vascular rings.
10. Isles CG, Hole DJ, Hawthorne VM, Lever AF: Relation between coronary risk and coronary mortality in women of the Refew and Paisely survey: Comparison with men. Lancet 1992, 339:702-706.
11. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH: Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991, 325:756-762.
12. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 228:373-376.
13. Moncada S, Palmer RM, Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
14. Rubanyi GM: The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993, 22(suppl):S1-14.
15. Rubanyi GM, Romero JC, Vanhoutte PM: Flow-induced release of endothelium-derived relaxing factor. Am J Physiol 1986, 250:H1145-1149.
16. Miller VM, Aarthus LL, Vanhoutte PM: Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol 1986, 251:H520-H527.
17. Yoshizumi M, Perrella MA, Burnett JC, Lee M: Tumor necrosis factor down-regulated an endothelial nitric oxide synthase mRNA by shortening its halflife. Circ Res 1993, 73:205-209.
18. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, et al.: Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. J Biol Chem 1997, 272:25437-25440. This study demonstrates inhibition of NOS-3 activity by specific interaction with caveolin-1.
19. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC: Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998, 392:821-824. This study shows the stimulus-dependent association of HSP90 with NOS-3, which results in increased activity of the enzyme.
20. Shaul PW, Smart EJ. Robinson LJ, German Z, Yuhanna IS, Ying Y, et al.: Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 1996, 271:6518-6522.
21. 2+-calmodulin and caveolin. J Biol Chem 1997, 272:15583-15586.
22. Dimmeler S, Fissthaler B, Fleming I, Assmus B, Hermann C, Zeiher AM: Shear stress stimulates the protein kinese Akt: Involvement in regulation of the endothelial nitric oxide synthase [abstract]. Circulation 1998, 17:1-312.
23. Kauser K, Rubanyi GM: Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension 1995, 25:517-523.
24. Gisclard V, Miller VM, Vanhoutte PM: Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988, 244:19-22.
25. Kauser K, Rubanyi GM: Effect of 17β-estradiol on endothelial dysfunction in the aorta of spontaneously hypertensive rats. Endothelium 1995, 25:517-523.
26. Williams JK, Adams MR, Klopfenstein HS: Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990, 81:1680-1687.
27. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA: Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994, 89:52-60.
28. Gilligan DM, Quyyurni AA, Cannon RO 3d, Johnson GB, Schenke WH: Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994, 89:2545-2551.
29. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK: Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17b-estradiol and norethisterone acetate. Hypertension 1995, 25:848-853.
30. Sudhir K, Jennings GL, Funder JW, Kornesaroff PA: Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension 1996, 28:330-334.
31. Hishikawa K, Makaki T, Marumo T, Suzuki H, Kato R, Saruta T: Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 1995, 36:291-293.
32. Hayashi TK, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, et al.: Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995, 214:847-855.
33. MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS, Shaul PW: Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 1997, 81:355-362. This study shows the effect of 17β-estradiol in regulating NOS-3 expression in fetal pulmonary artery endothelium through an ER-dependent mechanism.
34. Bayard F, Clamens S, Delson G, Blaes N, Maret A, Faye, J-C: Oestrogen synthesis, oestrogen metabolism and functional oestrogen receptors in bovine aortic endothelial cells. In Non-Reproductive Actions of Sex Steroids 191. Ciba Foundation Symposium, Chichester: John Wiley and Sons; 1995:122-138.
35. Venema RC, Nishida K, Alexander RW, Harrison DG, Murphy TJ: Organization of the bovine gene encoding the endothelial nitric oxide synthase. Biochem Biophys Acta 1994, 1218:413-420.
36. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Forstermann U: Estrogens increase transcription of the human endothelial NO synthase gene: Analysis of the transcription factors involved. Hypertension 1998, 31:582-588. In this study, a NOS-3 promoter-luciferase construct is used to demonstrate transcriptional regulation of NOS-3 by 17α-ethinyl-estradiol. The roles of potential transcription factors are examined.
37. Weiner CP, Knowles RG, Moncada S: Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 1994, 171:838-843.
38. Goetz RM, Morano I, Calvoni T, Studer R, Holtz J: Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 1994, 205:905-910.
39. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME: Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992, 90:1168-1172.
40. Creager MA, Girerd XJ, Gallagher SH, Coleman S, Dzau VJ, Cooke JP: L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992, 90:1248-1253.
41. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G: Gender differences in atherosclerosis: Possible role of nitric oxide. J Cardiovasc Pharmacol 1995, 26:792-802.
42. Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, et al.: Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997, 99:41-46.
43. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS: Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 1994, 93:2236-2243.
44. Hattori Y, Gross SS: GTP-cyclohydrolase 1 mRNA is induced by LPS in vascular smooth muscle: Characterization, sequence and relationship to nitric oxide synthase. Biochem Biophys Res Commun 1993, 195:435-441.
45. Bouhoute A, Leclercq G: Modulation of estradiol and DNA binding to estrogen receptor upon association with calmodulin. Biochem Biophys Res Commun 1995, 208:748-755.
46. Matsui K, Higashi K, Fukunga K, Miyazaki K, Maeyama M, Miyamoto E: Hormone treatments and pregnancy alter myosin light chain kinase and calmodulin levels in rabbit myometrium. J Endocrinol 1983, 97:11-16.
47. 2+-independent NO release from endothelial cells in response to estrogen. This article describes a cell culture method for human umbilical vein endothelial cells that seems to prevent loss of ER in culture.
48. Wyckoff MH, Yuhanna IS, Pace MC: Plasma membrane-associated estrogen receptors mediate the acute activation of eNOS by estrogen. Circulation 1998, 17:1-313.
49. Arnal JF, Clamens S, Pechet C, Negre-Salvayre A, Allera C, Girolami JP, et al.: Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci U S A 1996, 93:4108-4113.
50. Rubanyi GM, Vanhoutte PM: Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol 1986, 250:H815-H821.
51. Mooradian AD: Antioxidant properties of steroids. J Steroid Biochem Mol Biol 1993, 45:509-511.
52. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, et al.: Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta: Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 1997, 99:2429-2437. This study used isolated vessels from homozygous ERα-deficient mice to demonstrate, for the first time, the role of ERα in the regulation of NO-dependent vasorelaxation.
53. Lubahn DB, Moyer JS, Golding TS, Course JF, Korach KS, Smithies O: Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci U S A 1993, 90:11162-11166.
54. Kuiper GGJ, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A: Closing of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci U S A 1996, 93:5925-5930.
55. Mosselman S, Polman J, Dijkema R: ER-β: Identification and characterization of a novel human estrogen receptor. FEBS Lett 1996, 392:49-53.
56. Iyengar R, Stuehr DJ, Marletta MA: Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: Precursors and role of the respiratory burst. Proc Natl Acad Sci U S A 1985, 84:6369-6373.
57. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM: Nitric oxide: A cytotoxic activated macrophage offector molecule. Biochem Biophys Res Commun 1989, 157:87-94.
58. Thiemermann C, Vane JR: Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopotysaccharides in the rat in in vivo. Eur J Pharmacol 1990, 182:591-595.
59. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, et al.: Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256:225-228.
60. Geller DA, Nussler AK, Di Silvio M, Löwenstein CJ, Shapiro RA, Wang SC, et al.: Cytokines, endotoxin and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci U S A 1993, 90:522-526.
61. Xie Q, Whisnant R, Nathan C: Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon-γ and bacterial lipopolysaccharide. J Exp Med 1993, 177:1779-1784.
62. DiRosa M, Radomski M, Carnuccio R, Moncada S: Glucocorticoids inhibit the induction of nitric oxide synthase in macrophages. Biochem Biophys Res Commun 1990, 172:1245-1252.
63. Schmidt HHHW, Warner TD, Nakane M, Forstermann U, Murad F: Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. Mol Pharmacol 1992, 41:615-624.
64. Hirokawa K, O'Shaughnessy KM, Ramrakha P, Wilkins MR: Inhibition of nitric oxide synthesis in vascular smooth muscle by retinoids. Br J Pharmacol 1994, 113:144B-1454.
65. Pittner RA, Spitzer JA: Steroid hormones inhibit induction of spontaneous nitric oxide production in cultured hepatocytes without changes in arginase activity or urea production. Proc Soc Exp Biol Med 1993, 202:499-504.
66. Chao T-C, VanAlten PJ, Walter RJ: Steroid sex hormones and macrophage function: Modulation of reactive oxygen intermediates and nitrite release. Am J Reprod Immunol 1994, 32:43-52.
67. Hecker M, Preiss C, Klemm P, Busse R: Inhibition by antioxidants of nitric oxide synthase expression in murine macrophages: Role of nuclear factor kappa B and interferon regulatory factor 1. Br J Pharmacol 1996, 118:2178-2184.
68. Hayashi T, Yamada K, Esaki T, Muto E, Chaudhuri G, Iguchi A: Physiological concentrations of 17beta-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. J Cardiovasc Pharmacol 1998, 31:292-298. This study used activated macrophages to demonstrate the ER-mediated inhibitory effect of 17β-estradiol on NOS-2 expression.
69. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, et al.: Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest 1996, 75:77-85.
70. Russell ME, Wallace AF, Wyner LR, Newell JB, Karnovsky MJ: Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation 1995, 92:457-464.
71. Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR: Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 1994, 375:81-88.
72. Sobey CG, Brooks RM 2d, Heistad DD: Evidence that expression of inducible nitric oxide synthase in response to endotoxin is augmented in atherosclerotic rabbits. Circ Res 1995, 77:536-543.
73. Sarih M, Souvannanong V, Adam A: Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 1993, 191:503-508.
74. Albina JE, Cui S, Mateo RB, Reichner JS: Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993, 150:5080-5085.
75. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 1990, 87:682-685.
76. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH: Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron 1991, 7:615-624.
77. Nakane M, Schmidt HHHW, Pollock JS, Forstermann U, Murad F: Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993, 316:175-180.
78. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265:1883-1885.
79. Kornau H-C, Schenker LT, Kennedy MB, Seeburg PH: Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 1995, 269:1737-1740.
80. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, et al.: Interaction of nitric oxide synthase with the synaptic density protein PSD-95 and a-1 syntrophin mediated by PDZ domains. Cell 1996, 84:757-767.
81. Zhang YQ, Shi J, Rajakumar G, Day AL, Simpkins JW: Effects of gender and estradiol treatment on focal brain ischemia. Brain Res 1998, 784:321-324. This study demonstrated the sex- and estrogen-dependent effects on mortality and focal cerebral ischemic damage induced by unilateral middle cerebral artery occlusion in rats.
82. Paganini-Hill A: Estrogen replacement therapy and stroke. Prog Cardiovasc Dis 1995, 38:223-242.
83. Petitti DB, Sidney S, Quesenberry CP Jr, Bernstein A: Ischemic stroke and use of estrogen and estrogen/progestogen as hormone replacement therapy. Stroke 1998, 29:23-28. This case-control epidemiologic study indicates that postmenopausal hormone replacement is not associated with an increase or decrease in risk for ischemic stroke.
84. Goodman Y, Bruce AJ, Cheng B, Mattson MP: Estrogens attenuate and cortirosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hyppocampal neurons. J Neurochem 1996, 66:1836-1844.
85. Traystman RJ: NO and the regulation of cerebral circulation in stroke [abstract]. Nitric Oxide 1998, 2:75.
86. Pelligrino DA, Santizo R, Baughman VL, Wang O: Cerebral vasodilating capacity during forebrain ischemia: Effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthase. Neuroreport 1998, 9:3285-3291. This article shows that physiologic doses of 17β-estradiol may promote neuroprotection through increased vasodilating capacity. Normalization of NOS-1 activity alone is not sufficient for recovery.
87. Palmon SC, Williams MJ, Littleton-Kearney MT, Traystman RJ, Kosk-Kosicka D, Hurn PD: Estrogen increases cGMP in selected brain regions and in cerebral microvessels. J Cereb Blood Flow Metab 1998, 18:1248-1252. This article describes the use of brain tissue from female rabbits in determining the cyclic GMP-mediated effects of 17β-estradiol.
88. G-methyl-L-arginine. J Cardiovasc Pharmacol 1992, 20(suppl 12):S132-S134.
89. Nava E, Palmer RMJ, Moncada S: Inhibition of nitric oxide synthesis in septic shock: How much is beneficial? Lancet 1991, 338:1555-1557.
90. Harbrecht BG, Billiar TR, Stadler J: Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical mediated hepatic injury. J Leukoc Biol 1992, 52:390-394.